MPM Oncology Innovations Fund GP LLC - Insider Trades & Share Buys/Sales

Real time insider trading transaction history:

Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
Shares are not adjusted for stock split.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Insider Trading Transactions for MPM Oncology Innovations Fund GP LLC

Common stock purchase or sale:

Transaction Date	Reported DateTime	Company	Symbol	Insider Relationship	Shares Traded	Average Price	Total Amount	Shares Owned	Filing
2025-12-02 Sale	2025-12-04 6:18 pm	Werewolf Therapeutics Inc.	HOWL	GADICKE ANSBERT MPM ONCOLOGY INNOVATIONS FUND LP UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM BioImpact LLC MPM Oncology Innovations Fund GP LLC MPM ASSET MANAGEMENT LLC Former 10% Owner	199,732	$0.91761	$183,275	4,784,111 (Indirect)	View
2025-11-26 Sale	2025-12-01 6:11 pm	Werewolf Therapeutics Inc.	HOWL	GADICKE ANSBERT MPM ONCOLOGY INNOVATIONS FUND LP UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM BioImpact LLC MPM Oncology Innovations Fund GP LLC MPM ASSET MANAGEMENT LLC 10% Owner	141,927	$0.96426	$136,855	4,983,843 (Indirect)	View
2025-11-21 Sale	2025-11-25 6:03 pm	Werewolf Therapeutics Inc.	HOWL	GADICKE ANSBERT MPM ONCOLOGY INNOVATIONS FUND LP UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM BioImpact LLC MPM Oncology Innovations Fund GP LLC MPM ASSET MANAGEMENT LLC 10% Owner	195,666	$0.91764	$179,551	5,125,770 (Indirect)	View
2025-11-18 Sale	2025-11-20 5:50 pm	Werewolf Therapeutics Inc.	HOWL	GADICKE ANSBERT MPM ONCOLOGY INNOVATIONS FUND LP UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM BioImpact LLC MPM Oncology Innovations Fund GP LLC MPM ASSET MANAGEMENT LLC 10% Owner	160,103	$0.92386	$147,913	5,321,436 (Indirect)	View
2025-11-13 Sale	2025-11-17 7:20 pm	Werewolf Therapeutics Inc.	HOWL	GADICKE ANSBERT MPM ONCOLOGY INNOVATIONS FUND LP UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM BioImpact LLC MPM Oncology Innovations Fund GP LLC MPM ASSET MANAGEMENT LLC 10% Owner	209,652	$0.95713	$200,665	5,481,539 (Indirect)	View
2025-11-07 Sale	2025-11-12 7:31 pm	Werewolf Therapeutics Inc.	HOWL	GADICKE ANSBERT MPM ONCOLOGY INNOVATIONS FUND LP UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM BioImpact LLC MPM Oncology Innovations Fund GP LLC MPM ASSET MANAGEMENT LLC 10% Owner	213,529	$1.13	$241,278	5,691,191 (Indirect)	View
2025-11-04 Sale	2025-11-06 7:40 pm	Werewolf Therapeutics Inc.	HOWL	GADICKE ANSBERT MPM ONCOLOGY INNOVATIONS FUND LP UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM BioImpact LLC MPM Oncology Innovations Fund GP LLC MPM ASSET MANAGEMENT LLC 10% Owner	242,890	$1.2178	$295,781	5,904,720 (Indirect)	View
2025-10-30 Sale	2025-11-03 7:07 pm	Werewolf Therapeutics Inc.	HOWL	GADICKE ANSBERT MPM ONCOLOGY INNOVATIONS FUND LP UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM BioImpact LLC MPM Oncology Innovations Fund GP LLC MPM ASSET MANAGEMENT LLC 10% Owner	295,043	$1.3274	$391,636	6,147,610 (Indirect)	View
2025-10-27 Sale	2025-10-29 7:21 pm	Werewolf Therapeutics Inc.	HOWL	GADICKE ANSBERT MPM ONCOLOGY INNOVATIONS FUND LP UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM BioImpact LLC MPM Oncology Innovations Fund GP LLC MPM ASSET MANAGEMENT LLC 10% Owner	276,017	$1.6173	$446,403	6,442,653 (Indirect)	View
2025-03-27 Sale	2025-04-30 4:08 pm	Werewolf Therapeutics Inc.	HOWL	GADICKE ANSBERT MPM ONCOLOGY INNOVATIONS FUND LP UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM BioImpact LLC MPM Oncology Innovations Fund GP LLC MPM ASSET MANAGEMENT LLC 10% Owner	4,386	$1.05	$4,605	6,718,670 (Indirect)	View
2021-05-04 Purchase	2021-05-06 4:19 pm	Werewolf Therapeutics Inc.	HOWL	GADICKE ANSBERT MPM ONCOLOGY INNOVATIONS FUND LP UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management LP MPM Oncology Innovations Fund GP LLC MPM Oncology Impact Management GP LLC 10% Owner	245,000	$16	$3,920,000	6,672,183 (Indirect)	View

Stock options: Exercise, Award, Grant, Conversion

Transaction Date	Reported DateTime	Exercisable Expiration	Company	Symnbol	Insider Relationship	Shares Traded	Conversion Price	Shares Owned	Filing
2025-03-27 Exercise	2025-04-30 4:08 pm	N/A N/A	Werewolf Therapeutics Inc.	HOWL	GADICKE ANSBERT MPM ONCOLOGY INNOVATIONS FUND LP UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM BioImpact LLC MPM Oncology Innovations Fund GP LLC MPM ASSET MANAGEMENT LLC 10% Owner	50,873	$0.09	6,718,670 (Indirect)	View
2025-03-27 Exercise	2025-04-30 4:08 pm	N/A 2025-04-09	Werewolf Therapeutics Inc.	HOWL	GADICKE ANSBERT MPM ONCOLOGY INNOVATIONS FUND LP UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM BioImpact LLC MPM Oncology Innovations Fund GP LLC MPM ASSET MANAGEMENT LLC 10% Owner	50,873	$0	6,718,670 (Indirect)	View
2021-05-04 Conversion	2021-05-06 4:19 pm	N/A N/A	Werewolf Therapeutics Inc.	HOWL	GADICKE ANSBERT MPM ONCOLOGY INNOVATIONS FUND LP UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management LP MPM Oncology Innovations Fund GP LLC MPM Oncology Impact Management GP LLC 10% Owner	57,683,698	$0	6,672,183 (Indirect)	View
Ownership	2021-04-29 5:31 pm	N/A N/A	Werewolf Therapeutics Inc.	HOWL	GADICKE ANSBERT MPM ONCOLOGY INNOVATIONS FUND LP UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management LP MPM Oncology Innovations Fund GP LLC MPM Oncology Impact Management GP LLC 10% Owner	0	$0	6,486,087 (Indirect)	View

MPM Oncology Innovations Fund GP LLC - Insider Trading & Ownership